Drug Safety

, Volume 18, Issue 4, pp 221–250 | Cite as

Adverse Effects and Drug Interactions Associated with Local and Regional Anaesthesia

  • Mohamed Naguib
  • Magboul M. A. Magboul
  • Abdulhamid H. Samarkandi
  • Mounir Attia
Drug Experience


Systemic and localised adverse effects of local anaesthetic drugs usually occur because of excessive dosage, rapid absorption or inadvertent intravascular injection.

Small children are more prone than adults to methaemoglobinaemia, and the combination of sulfonamides and prilocaine, even when correctly administered, should be avoided in this age group. The incidence of true allergy to local anaesthetics is rare.

All local anaesthetics can cause CNS toxicity and cardiovascular toxicity if their plasma concentrations are increased by accidental intravenous injection or an absolute overdose. Excitation of the CNS may be manifested by numbness of the tongue and perioral area, and restlessness, which may progress to seizures, respiratory failure and coma. Bupivacaine is the local anaesthetic most frequently associated with seizures. Treatment of CNS toxicity includes maintaining adequate ventilation and oxygenation, and controlling seizures with the administration of thiopental sodium or benzodiazepines.

Cardiovascular toxicity generally begins after signs of CNS toxicity have occurred. Bupivacaine and etidocaine appear to be more cardiotoxic than most other commonly used local anaesthetics. Sudden onset of profound bradycardia and asystole during neuraxial blockade is of great concern and the mechanism(s) remains largely unknown. Treatment of cardiovascular toxicity depends on the severity of effects. Cardiac arrest caused by local anaesthetics should be treated with cardiopulmonary resuscitation procedures, but bupivacaine-induced dysrhythmias may be refractory to treatment.

Many recent reports of permanent neurological complications involved patients who had received continuous spinal anaesthesia through a microcatheter. Injection of local anaesthetic through microcatheters and possibly small-gauge spinal needles results in poor CSF mixing and accumulation of high concentrations of local anaesthetic in the areas of the lumbosacral nerve roots. In contrast to bupivacaine, the hyperbaric lidocaine (lignocaine) formulation carries a substantial risk of neurotoxicity when given intrathecally.

Drugs altering plasma cholinesterase activity have the potential to decrease hydrolysis of ester-type local anaesthetics. Drugs inhibiting hepatic microsomal enzymes, such as cimetidine, may allow the accumulation of unexpectedly high (possibly toxic) blood concentrations of lidocaine. Reduction of hepatic blood flow by drugs or hypotension will decrease the hepatic clearance of amide local anaesthetics. Special caution must be exercised in patients taking digoxin, calcium antagonists and/or β-blockers.


Lidocaine Adis International Limited Clonidine Bupivacaine Spinal Anesthesia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Catterall WA. Common modes of drug action on Na+ channels: local anesthetics, antiarrhythmics, and anticonvulsants. Trends Pharmacol Sci 1987; 8: 57–65CrossRefGoogle Scholar
  2. 2.
    Al-Mazrooa AA, Abdel-Halim RE. Anaesthesia 1000 years ago. In: Atkinson RS, Boulton TB, editors. The history of anaesthesia. International Congress and Symposium series Number 134. London: The Parthenon Publishing Group, 1989: 46–8Google Scholar
  3. 3.
    Koller C. Ueber die Verwendung des Cocain zur Anaesthesierung am Auge. Wien Med Wochenschr 1884; 34: 1276–8Google Scholar
  4. 4.
    Boyes RM, Scott DB, Jebson PJ, et al. Pharmacokinetics of lidocaine in man. Clin Pharmacol Ther 1971; 12: 105–16PubMedGoogle Scholar
  5. 5.
    Aldrete JA, Romo-Salas F, Arora S, et al. Reverse arterial blood flow as a pathway for central nervous system toxic responses following injection of local anesthetics. Anesth Analg 1978; 57: 428–33PubMedCrossRefGoogle Scholar
  6. 6.
    Meyers EF, Ramirez RC, Boniuk I. Grand mal seizures after retrobulbar block. Arch Ophthalmol 1978; 96: 847PubMedCrossRefGoogle Scholar
  7. 7.
    Nau H. Clinical pharmacokinetics in pregnancy and perinatology. I: placental transfer and fetal side effects of local anaesthetic agents. Dev Pharmacol Ther 1985; 8: 149–81PubMedGoogle Scholar
  8. 8.
    Covino BG. Pharmacokinetics of local anesthetic drugs. In: Prys-Roberts C, Hug Jr C, editors. Pharmacokinetics of anesthesia. Oxford: Blackwell Scientific Publications, 1984: 202Google Scholar
  9. 9.
    Bromage PR, Robson JG. Concentrations of lidocaine in the blood after intravenous, intramuscular, epidural, and endotracheal administration. Anaesthesia 1961; 16: 461–78PubMedCrossRefGoogle Scholar
  10. 10.
    Wildsmith JA, Tucker GT, Cooper S, et al. Plasma concentrations of local anaesthetics after interscalene brachial plexus block. Br J Anaesth 1977; 49: 461–6PubMedCrossRefGoogle Scholar
  11. 11.
    Covino BG. Comparative clinical pharmacology of local anaesthetic agents. Anesthesiology 1971; 35: 158–67PubMedCrossRefGoogle Scholar
  12. 12.
    Anaesthetists and the reporting of adverse drug reactions. BMJ 1986; 292: 949Google Scholar
  13. 13.
    Naguib M, Magboul MMA, Jaroudi R. Clinically significant drug interactions with general anaesthetics: incidence, mechanisms and management. CNS Drugs 1997; 8: 51–78CrossRefGoogle Scholar
  14. 14.
    Olson ML, McEvoy GK. Methemoglobinemia induced by local anesthetics. Am J Hosp Pharm 1981; 38: 89–93PubMedGoogle Scholar
  15. 15.
    Severinghaus JW, Xu Fa-Di, Spellman Jr MJ. Benzocaine and methemoglobin: recommended action [letter]. Anesthesiology 1991; 74: 385PubMedCrossRefGoogle Scholar
  16. 16.
    Sherman JM, Smith K. Methemoglobinemia owing to rectal-probe lubrication [letter]. Am J Dis Child 1979; 133: 439PubMedGoogle Scholar
  17. 17.
    Seibert RW, Seibert JJ. Infantile methemoglobinemia induced by a topical anesthetic, cetacaine. Laryngoscope 1984; 94: 816–7PubMedGoogle Scholar
  18. 18.
    Bhatt DN, Bifano EM, Stark DCC. Postoperative methemoglobinemia in a neonate [letter]. Anesthesiology 1985; 62: 210–1PubMedCrossRefGoogle Scholar
  19. 19.
    Kellett PB, Copeland CS. Methemoglobinemia associated with benzocaine-containing lubricant. Anesthesiology 1983; 59: 463–4PubMedCrossRefGoogle Scholar
  20. 20.
    Ferraro-Borgida MJ, Mulhern SA, DeMeo MO, et al. Methemoglobinemia from perineal application of an anesthetic cream. Ann Emerg Med 1996; 27: 785–8PubMedCrossRefGoogle Scholar
  21. 21.
    O’Donohue Jr WJ, Moss LM, Angelilo VA. Acute methemoglobinemia induced by topical benzocaine and lidocaine. Arch Intern Med 1980; 140: 1508–9PubMedCrossRefGoogle Scholar
  22. 22.
    Spielman FJ, Anderson JA, Terry WC. Benzocaine-induced methemoglobinemia during general anesthesia. J Oral Maxillofac Surg 1984; 42: 740–3PubMedCrossRefGoogle Scholar
  23. 23.
    Potter JL, Hillman JV. Benzocaine-induced methemoglobinemia. J Am Coll Emerg Phys 1979; 8: 26–7CrossRefGoogle Scholar
  24. 24.
    Jakobson B, Nilsson A. Methemoglobinaemia associated with a prilocaine-lidocaine cream and trimetoprim-sulphamethoxazole: a case report. Acta Anaesthesiol Scand 1985; 29: 453–5PubMedCrossRefGoogle Scholar
  25. 25.
    Engberg G, Danielson K, Henneberg S, et al. Plasma concentrations of prilocaine and lidocaine and methaemoglobin formation in infants after epicutaneous application of a 5% lidocaine-prilocaine cream (EMLA). Acta Anaesthesiol Scand 1987; 31: 624–8PubMedCrossRefGoogle Scholar
  26. 26.
    Duncan PG, Kobrinsky N. Prilocaine-induced methemoglobinemia in a newborn infant. Anesthesiology 1983; 59: 75–6PubMedCrossRefGoogle Scholar
  27. 27.
    Kreutz RW, Kinni ME. Life-threatening toxic methemoglobinemia induced by prilocaine. Oral Surg 1983; 56: 480–2PubMedCrossRefGoogle Scholar
  28. 28.
    Frayling IM, Addison GM, Chattergee K, et al. Methaemoglobinaemia in children treated with prilocaine-lignocaine cream. BMJ 1990; 301: 153–4PubMedCrossRefGoogle Scholar
  29. 29.
    Bardoczky GI, Wathieu M, D’Hollander A. Prilocaine-induced methemoglobinemia evidenced by pulse oximetry. Acta Anaesthesiol Scand 1990; 34: 162–4PubMedCrossRefGoogle Scholar
  30. 30.
    Klos CP, Hays GL. Prilocaine-induced methemoglobinemia in a child with Shwachman syndrome. J Oral Maxillofac Surg 1985; 43: 621–3PubMedCrossRefGoogle Scholar
  31. 31.
    Weiss LD, Generalovich T, Heller MB, et al. Methemoglobin levels following intravenous lidocaine administration. Ann Emerg Med 1987; 16: 323–5PubMedCrossRefGoogle Scholar
  32. 32.
    Nilsson A, Engberg G, Henneberg S, et al. Inverse relationship between age-dependent erythrocyte activity of methaemoglobin reductase and prilocaine-induced methaemoglobinaemia during infancy. Br J Anaesth 1990; 64: 72–6PubMedCrossRefGoogle Scholar
  33. 33.
    Curry S. Methemoglobinemia. Ann Emerg Med 1982; 11: 214–21PubMedCrossRefGoogle Scholar
  34. 34.
    Reynolds F. Adverse effects of local anaesthetics. Br J Anaesth 1987; 59: 78–95PubMedCrossRefGoogle Scholar
  35. 35.
    Finch CA. Methemoglobinemia and sulfhemoglobinemia. N Engl J Med 1948; 239: 470–8PubMedCrossRefGoogle Scholar
  36. 36.
    Hall AH, Kulig KW, Rumack BH. Drug- and chemical-induced methaemoglobinaemia: clinical features and management. Med Toxicol 1986; 1: 253–60PubMedGoogle Scholar
  37. 37.
    Barker SJ, Tremper KK, Hyatt J. Effects of methemoglobinemia on pulse oximetry and mixed venous oximetry. Anesthesiology 1989; 70: 112–7PubMedCrossRefGoogle Scholar
  38. 38.
    Anderson ST, Hajduczek J, Barker SJ. Benzocaine-induced methemoglobinemia in an adult: accuracy of pulse oximetry with methemoglobinemia. Anesth Analg 1988; 67: 1099–101PubMedGoogle Scholar
  39. 39.
    Choe H, Tashiro C, Fukumitsu K, et al. Comparison of recorded values from six pulse oximeters. Crit Care Med 1989; 17: 678–81PubMedCrossRefGoogle Scholar
  40. 40.
    Lukens JN. Methemoglobinemia and other diseases accompanied by cyanosis. In: Lee GR, Bithell TC, Foerster J, editors. Wintrobe’s clinical hematology. 9th edition. Philadelphia: Lea & Febiger, 1993: 1262–71Google Scholar
  41. 41.
    Odoom JA, Dokter PWC, Sturk A, et al. The influence of epidural analgesia on platelet function and correlation with plasma bupivacaine concentrations. Eur J Anaesthesiol 1988; 5: 305–12PubMedGoogle Scholar
  42. 42.
    Modig J, Borg T, Karlström G, et al. Thromboembolism after total hip replacement: role of epidural and general anesthesia. Anesth Analg 1983; 62: 174–80PubMedCrossRefGoogle Scholar
  43. 43.
    McKenzie PJ, Wishart HY, Gray I, et al. Effects of anaesthetic techniques on deep vein thrombosis: a comparison of subarachnoid and general anaesthesia. Br J Anaesth 1985; 57: 853–7PubMedCrossRefGoogle Scholar
  44. 44.
    Bowler GMR, Lamont MC, Scott DB. Effect of extradural bupivacaine or i.v. diamorphine on calf blood flow in patients after surgery. Br J Anaesth 1987; 59: 1412–9PubMedCrossRefGoogle Scholar
  45. 45.
    Davis FM, McDermott E, Hickton C, et al. Influence of spinal and general anaesthesia on haemostasis during total hip arthroplasty. Br J Anaesth 1987; 59: 561–71PubMedCrossRefGoogle Scholar
  46. 46.
    Modig J, Borg T, Bagge EL, et al. Role of extradural and general anaesthesia in fibrinolysis and coagulation after total hip replacement. Br J Anaesth 1983; 53: 625–9CrossRefGoogle Scholar
  47. 47.
    Henny CP, Odoom JA, Ten Cate H, et al. Effects of extradural bupivacaine on the haemostatic system. Br J Anaesth 1986; 58: 301–5PubMedCrossRefGoogle Scholar
  48. 48.
    Giddon DB, Lindhe J. In vivo quantitation of local anesthetic suppression of leukocyte adherence. Am J Pathol 1972; 68: 327–38PubMedGoogle Scholar
  49. 49.
    Chen RYZ, Lee MM, Chien S. Local anesthetics and the rheologic behavior of erythrocyte suspension. Anesthesiology 1979; 51: 245–50PubMedCrossRefGoogle Scholar
  50. 50.
    Odoom JA, Bovill JG, Hardeman MR, et al. Effects of epidural and spinal anesthesia on blood rheology. Anesth Analg 1992; 74: 538–40CrossRefGoogle Scholar
  51. 51.
    Hammer R, Dahlgren C, Stendahl O. Inhibition of human leukocyte metabolism and random mobility by local anaesthesia. Acta Anaesthesiol Scand 1985; 29: 520–3PubMedCrossRefGoogle Scholar
  52. 52.
    Goldstein IM, Lind S, Hoffstein S, et al. Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro: reduction of lysosomal enzyme release and superoxide anion production. J Exp Med 1977; 146: 483–94PubMedCrossRefGoogle Scholar
  53. 53.
    Nakagawara M, Hirokata Y, Yoshitake J. Effects of anesthetics on superoxide releasing activity on human polymorphonuclear leukocytes. Masui 1985; 34: 754–9PubMedGoogle Scholar
  54. 54.
    Eriksson AS, Sinclair R, Cassuto J, et al. Influence of lidocaine on leukocyte function in the surgical wound. Anesthesiology 1992; 77: 74–8PubMedCrossRefGoogle Scholar
  55. 55.
    Kanta J, Kopacova L, Patockova M, et al. Effect of carbanilate local anesthetics on granulation tissue formation. Pol J Pharmacol Pharm 1984; 36: 659–63PubMedGoogle Scholar
  56. 56.
    Davies B, Guyuron B, Husami T. The role of lidocaine, epinephrine, and flap elevation in wound healing after chemical peel. Ann Plast Surg 1991; 26: 273–8PubMedCrossRefGoogle Scholar
  57. 57.
    Concepcion M, Covino BG. Rational use of local anaesthetics. Drugs 1984; 27: 256–70PubMedCrossRefGoogle Scholar
  58. 58.
    Sisk AL. Comparison of etidocaine and lidocaine for control of intra- and post-operative bleeding and pain. J Oral Maxillofac Surg 1986; 44: 16–20PubMedCrossRefGoogle Scholar
  59. 59.
    Jones RA, Di Fazio CA, Longnecker DE. Lidocaine constricts or dilates rat arterioles in a dose-dependent manner. Anesthesiology 1985; 62: 141–4CrossRefGoogle Scholar
  60. 60.
    Hogan Q. Local anesthetic toxicity: an update. Reg Anesth 1996; 21 Suppl. 6: 43–50PubMedGoogle Scholar
  61. 61.
    Sprung J, Lesitsky MA, Jagetia A, et al. Cardiac arrest caused by coronary spasm in two patients during recovery from epidural anesthesia. Reg Anesth 1996; 21: 253–60PubMedGoogle Scholar
  62. 62.
    Brockway MS, Bannister J, McClure JH, et al. Comparison of extradural ropivacaine and bupivacaine. Br J Anaesth 1991; 66: 31–7PubMedCrossRefGoogle Scholar
  63. 63.
    De Jong RH. Toxic effects of local anesthetics. JAMA 1978; 239: 1166–8PubMedCrossRefGoogle Scholar
  64. 64.
    Liu P, Feldman HS, Giasi, et al. Comparative CNS toxicity of lidocaine, etidocaine, bupivacaine and tetracaine in awake dogs following rapid intravenous administration. Anesth Analg 1983; 62: 375–9PubMedCrossRefGoogle Scholar
  65. 65.
    Garner L, Stirt J, Finholt D. Heart block after intravenous lidocaine in an infant. Can Anaesth Soc J 1985; 32: 425–8PubMedCrossRefGoogle Scholar
  66. 66.
    Heavner JE, Dryden Jr CF, Sanghani V, et al. Severe hypoxia enhances central nervous system and cardiovascular toxicity of bupivacaine in lightly anesthetized pigs. Anesthesiology 1992; 77: 142–7PubMedCrossRefGoogle Scholar
  67. 67.
    Avery P, Reden D, Schaenzer G, et al. The influence of serum potassium on the cerebral and cardiac toxicity of bupivacaine and lidocaine. Anesthesiology 1984; 61: 134–8PubMedCrossRefGoogle Scholar
  68. 68.
    Moller RA, Datta S, Fox J, et al. Effects of progesterone on the cardiac action electrophysiologic action of bupivacaine and lidocaine. Anesthesiology 1992; 76: 604–8PubMedCrossRefGoogle Scholar
  69. 69.
    Santos AC, Arthur GR, Wlody D, et al. Comparative systemic toxicity of ropivacaine and bupivacaine in nonpregnant and pregnant ewes. Anesthesiology 1995; 82: 734–40PubMedCrossRefGoogle Scholar
  70. 70.
    Thomas RD, Behbehani MM, Coyle DE, et al. Cardiovascular toxicity of local anesthetics. An alternative hypothesis. Anesth Analg 1986; 65: 444–50PubMedCrossRefGoogle Scholar
  71. 71.
    Blair MR. Cardiovascular physiology of local anaesthetics. Br J Anaesth 1975; 47 Suppl.: 247–52PubMedGoogle Scholar
  72. 72.
    Cardiotoxicity of local anaesthetic drugs [editorial]. Lancet 1986; II: 1192-4Google Scholar
  73. 73.
    Albright GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine [editorial]. Anesthesiology 1979; 51: 285–7PubMedCrossRefGoogle Scholar
  74. 74.
    Nath S, Häggmark S, Johnasson G, et al. Differential depressant and electrophysiologic cardiotoxicity of local anesthetics: an experimental study with special reference to lidocaine and bupivacaine. Anesth Analg 1986; 65: 1263–70PubMedCrossRefGoogle Scholar
  75. 75.
    Lynch C III. Depression of myocardial contractility in vitro by bupivacaine, etidocaine, and lidocaine. Anesth Analg 1986; 65: 551–9PubMedGoogle Scholar
  76. 76.
    Buffington CW. The magnitude and duration of direct myocardial depression following intracoronary local anesthetics: a comparison of lidocaine and bupivacaine. Anesthesiology 1989; 70: 280–7PubMedCrossRefGoogle Scholar
  77. 77.
    Fujita Y. Comparative direct effects of lidocaine and bupivacaine on regional myocardial function in dogs at non-cardiovascular toxic levels. Anesth Analg 1994; 78: 1158–63PubMedCrossRefGoogle Scholar
  78. 78.
    Reiz S, Häggmark S, Johansson G, et al. Cardiotoxicity of ropivacaine — a new amide local anaesthetic agent. Acta Anaesthesiol Scand 1989; 33: 93–8PubMedCrossRefGoogle Scholar
  79. 79.
    Kasten GW, Martin ST. Successful cardiovascular resuscitation after massive intravenous bupivacaine overdosage in anesthetized dogs. Anesth Analg 1985; 64: 491–7PubMedGoogle Scholar
  80. 80.
    Mazoit JX, Boico O, Samii K. Myocardial uptake of bupivacaine. II: pharmacokinetics and pharmacodynamics of bupivacaine enantiomers in the isolated perfused rabbit heart. Anesth Analg 1993; 44: 477–82Google Scholar
  81. 81.
    Clarkson CW, Hondeghem IM. Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology 1985; 62: 396–405PubMedCrossRefGoogle Scholar
  82. 82.
    Coyle DE, Sperelakis N. Bupivacaine and lidocaine blockade of calcium-mediated slow action potentials in guinea pig ventricular muscle. J Pharmacol Exp Ther 1987; 242: 1001–5PubMedGoogle Scholar
  83. 83.
    Sanchez-Chapula J. Effects of bupivacaine on membrane currents of guinea-pig ventricular myocytes. Eur J Pharmacol 1988; 156: 303–8PubMedCrossRefGoogle Scholar
  84. 84.
    Butterworth JF IV, Brownlow RC, Leith JP, et al. Bupivacaine inhibits cyclic-3′,5′-adenosine monophosphate production: a possible contributing factor to cardiovascular toxicity. Anesthesiology 1993; 79: 88–95PubMedCrossRefGoogle Scholar
  85. 85.
    Covino BG. Recent advances in local anesthesia. Can Anaesth Soc J 1986; 33: S5–S8PubMedCrossRefGoogle Scholar
  86. 86.
    Moore DC, Bridenbaugh LD. Spinal (subarachnoid) block: a review of 11,574 cases. JAMA 1966; 195: 907–12PubMedCrossRefGoogle Scholar
  87. 87.
    Moore DC, Bridenbaugh LD, Bagdi PA, et al. The present status of spinal (subarachnoid) and epidural (peridural) block: a comparison of two technics. Anesth Analg 1968; 47: 40–9PubMedGoogle Scholar
  88. 88.
    Moore DC, Bridenbaugh LD, Bridenbaugh PO, et al. Bupivacaine: a review of 2077 cases. JAMA 1970; 214: 713–8PubMedCrossRefGoogle Scholar
  89. 89.
    Bonica JJ, Berges PU, Morikawa K. Circulatory effects of peridural block. I: effects of level of analgesia and doses of lidocaine. Anesthesiology 1970; 33: 619–26PubMedCrossRefGoogle Scholar
  90. 90.
    Bonica JJ, Akamatsu TJ, Berges PU, et al. Circulatory effects of peridural block. II: effects of epinephrine. Anesthesiology 1971; 34: 514–22PubMedCrossRefGoogle Scholar
  91. 91.
    Wetstone DL, Wong KC. Sinus bradycardia and asystole during spinal anesthesia. Anesthesiology 1974; 41: 87–9PubMedCrossRefGoogle Scholar
  92. 92.
    Nishidawa T, Anzai Y, Namiki A. Asystole during spinal anaesthesia after changes from Trendelenburg to horizontal position. Can J Anaesth 1988; 35: 406–8CrossRefGoogle Scholar
  93. 93.
    Fredericks RL, Campbell J, Bassell GM. Psychologic cardiac arrest during extensive sympathetic blockade. Anesthesiology 1988; 68: 943–4CrossRefGoogle Scholar
  94. 94.
    Gild W, Grilley P. Sudden cardiac arrest during epidural anesthesia [letter]. Anesthesiology 1990; 73: 1296PubMedCrossRefGoogle Scholar
  95. 95.
    Mackey DC, Carpenter RL, Thompson GE, et al. Bradycardia and asystole during spinal anesthesia: a report of three cases without morbidity. Anesthesiology 1989; 70: 866–8PubMedCrossRefGoogle Scholar
  96. 96.
    Liguori GA, Sharrock NE. Asystole and severe bradycardia during epidural anesthesia in orthopedic patients. Anesthesiology 1997; 86: 250–7PubMedCrossRefGoogle Scholar
  97. 97.
    Chan KKM, Welch KJ. Cardiac arrest during segmental thoracic epidural anesthesia. Anesthesiology 1997; 86: 502–5Google Scholar
  98. 98.
    Caplan RA, Ward RJ, Posner K, et al. Unexpected cardiac arrest during spinal anesthesia: a closed claim analysis of predisposing factors. Anesthesiology 1988; 68: 5–11PubMedCrossRefGoogle Scholar
  99. 99.
    New classification of physical status. Anesthesiology 1963; 24: 111Google Scholar
  100. 100.
    Carpenter RL, Caplan RA, Brown DL, et al. Incidence and risk factors for side effects of spinal anesthesia. Anesthesiology 1992; 76: 906–16PubMedCrossRefGoogle Scholar
  101. 101.
    Liu S, Paul GE, Carpenter RL, et al. Prolonged PR interval is a risk factor for bradycardia during spinal anesthesia. Reg Anesth 1995; 20: 41–4PubMedGoogle Scholar
  102. 102.
    Keats AS. Anesthesia mortality — a new mechanism. Anesthesiology 1988; 68: 2–4PubMedCrossRefGoogle Scholar
  103. 103.
    Cohen LI. Asystole during spinal anesthesia in a patient with sick sinus syndrome. Anesthesiology 1988; 68: 787–8PubMedCrossRefGoogle Scholar
  104. 104.
    Tucker GT, Mather LE. Clinical pharmacokinetics of local anesthetics. Clin Pharmacokinet 1979; 4: 241–78PubMedCrossRefGoogle Scholar
  105. 105.
    Leicht CH, Carlson SA. Prolongation of lidocaine spinal anesthesia with epinephrine and phenylephrine. Anesth Analg 1986; 65: 365–9PubMedCrossRefGoogle Scholar
  106. 106.
    Feldman HS, Arthur GR, Covino BG. Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine and lidocaine in the conscious dog. Anesth Analg 1989; 69: 794–801PubMedGoogle Scholar
  107. 107.
    Moore DC, Crawford RD, Scurlock JE. Severe hypoxia and acidosis following local anesthetic induced convulsions. Anesthesiology 1980; 53: 259–60PubMedCrossRefGoogle Scholar
  108. 108.
    Mallampati SR, Liu PL, Knapp RM. Convulsion and ventricular tachycardia from bupivacaine with epinephrine; successful resuscitation. Anesth Analg 1984; 63: 856–9PubMedCrossRefGoogle Scholar
  109. 109.
    Davis NL, de Jong RH. Successful resuscitation following massive bupivacaine overdose. Anesth Analg 1982; 61: 62–4PubMedGoogle Scholar
  110. 110.
    Kendig JJ. Clinical implications of the modulated receptor hypothesis: local anesthetics and the heart [editorial]. Anesthesiology 1985; 62: 382–4PubMedCrossRefGoogle Scholar
  111. 111.
    Feldman HS, Arthur GR, Pitkanen M, et al. Treatment of acute systemic toxicity after the rapid intravenous injection of ropivacaine and bupivacaine in the conscious dog. Anesth Analg 1991; 73: 373–84PubMedCrossRefGoogle Scholar
  112. 112.
    Saitoh K, Hirabayashi Y, Shimizu R, et al. Amrinone is superior to epinephrine in reversing bupivacaine-induced cardiovascular depression in sevoflurane-anesthetized dogs. Anesthesiology 1995; 83: 127–33PubMedCrossRefGoogle Scholar
  113. 113.
    Lindgren L, Randell T, Suzuki N, et al. The effect of amrinone on recovery from severe bupivacaine intoxication in pigs. Anesthesiology 1992; 77: 309–15PubMedCrossRefGoogle Scholar
  114. 114.
    Heavner JE, Pitkänen MT, Shi B, et al. Resuscitation from bupivacaine-induced asystole in rats: comparison of different cardioactive drugs. Anesth Analg 1995; 80: 1134–9PubMedGoogle Scholar
  115. 115.
    Lacombe P, Blaise G, Hollmann C, et al. Isoproterenol corrects the effects of bupivacaine on the electrophysiologic properties of the isolated rabbit heart. Anesth Analg 1991; 72: 70–4PubMedGoogle Scholar
  116. 116.
    Hornchen U, Fischer M, Lauven PM, et al. The cardiotoxicity of bupivacaine during pacemaker stimulation is dependent on the stimulation frequency: results of an experimental study [in German]. Anaesthesist 1993; 42: 350–5PubMedGoogle Scholar
  117. 117.
    Matsuda F, Kinney WW, Wright W, et al. Nicardipine reduces the cardio-respiratory toxicity of intravenously administered bupivacaine in rats. Can J Anaesth 1990; 37: 920–3PubMedCrossRefGoogle Scholar
  118. 118.
    Solomon D, Bunegin L, Albin M. The effect of magnesium sulfate administration on cerebral and cardiac toxicity of bupivacaine in dogs. Anesthesiology 1990; 72: 341–6PubMedCrossRefGoogle Scholar
  119. 119.
    Kasten GW, Martin ST. Bupivacaine cardiovascular toxicity: comparison of treatment with bretylium and lidocaine. Anesth Analg 1985; 64: 911–6PubMedGoogle Scholar
  120. 120.
    Haasio J, Rosenberg PH. Treatment of bupivacaine-induced cardiac arrhythmias in hypoxic and hypercarbic pigs with amiodarone or bretylium. Reg Anesth 1990; 15: 174–9PubMedGoogle Scholar
  121. 121.
    Clarkson CW, Hondeghem LM. Evidence for a specific receptor site for lidocaine, quinidine, and bupivacaine associated with cardiac sodium channels in guinea pig ventricular myocardium. Circ Res 1985; 56: 496–506PubMedCrossRefGoogle Scholar
  122. 122.
    Maxwell LG, Martin LD, Yaster M. Bupivacaine-induced cardiac toxicity in neonates: successful treatment with intravenous phenytoin. Anesthesiology 1994; 80: 682–6PubMedCrossRefGoogle Scholar
  123. 123.
    Bigger JT, Hoffman BF. Antiarrhythmic drugs: the pharmacological basis of therapeutics. In: Gilman AG, Rall TW, Nies AS, et al., editors. New York: Pergamon Press, 1990: 840–73Google Scholar
  124. 124.
    De La Coussaye J, Bassoul B, Brugada J, et al. Reversal of electrophysiologic and hemodynamic effects induced by high dose of bupivacaine by the combination of clonidine and dobutamine in anesthetized dogs. Anesth Analg 1992; 74: 703–11Google Scholar
  125. 125.
    Wagman IH, De Jong RH, Prince DA. Effects of lidocaine on the central nervous system. Anesthesiology 1967; 28: 155–72PubMedCrossRefGoogle Scholar
  126. 126.
    Fruncillo RJ, Gibbons W, Bowman SM. CNS toxicity after ingestion of topical lidocaine. N Engl J Med 1982; 306: 426–7PubMedGoogle Scholar
  127. 127.
    Ryan CA, Robertson M, Coe JY. Seizures due to lidocaine toxicity in a child during cardiac catheterization. Pediatr Cardiol 1993; 14: 116–8PubMedCrossRefGoogle Scholar
  128. 128.
    Sundaram MBM. Seizures after intraurethral instillation of lidocaine. Can Med Assoc J 1987; 137: 219–20Google Scholar
  129. 129.
    Casale FF. Convulsions following surgery [letter]. Br J Anaesth 1970; 42: 1024PubMedCrossRefGoogle Scholar
  130. 130.
    McCloskey JJ, Haun SE, Deshpande JK. Bupivacaine toxicity secondary to continuous caudal epidural infusion in children. Anesth Analg 1992; 75: 287–90PubMedCrossRefGoogle Scholar
  131. 131.
    Tanaka K, Yamasaki M. Blocking of cortical inhibitory synapses by intravenous lidocaine. Nature 1966; 209: 207–8PubMedCrossRefGoogle Scholar
  132. 132.
    de Jong RH, Robles R, Corbin RW. Central actions of lidocaine-synaptic transmission. Anesthesiology 1969; 30: 19–23PubMedCrossRefGoogle Scholar
  133. 133.
    Huffman RD, Yim GK. Effects of diphenylaminoethanol and lidocaine on central inhibition. Int J Neuropharmacol 1969; 8: 217–25PubMedCrossRefGoogle Scholar
  134. 134.
    Eriksson E, Persson A. The effect of intravenously administered prilocaine and lidocaine on the human electroencephalogram studied by automatic frequency analysis. Acta Chir Scand 1966; 358 Suppl.: 37–46Google Scholar
  135. 135.
    Ding Z-N, Yoshita Y, Hirota K, et al. Brain stem auditory evoked potentials during procaine toxicity in dogs. Can J Anaesth 1992; 39: 600–3PubMedCrossRefGoogle Scholar
  136. 136.
    Scott DB, Lee A, Fagan D, et al. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69: 563–9PubMedGoogle Scholar
  137. 137.
    Agarwal R, Gutlove DP, Lockhart CH. Seizures occurring in pediatric patients receiving continuous infusion of bupivacaine. Anesth Analg 1992; 75: 284–6PubMedCrossRefGoogle Scholar
  138. 138.
    Berde CB. Convulsions associated with pediatric regional anesthesia [editorial]. Anesth Analg 1992; 75: 164–6PubMedCrossRefGoogle Scholar
  139. 139.
    Morishima HO, Finster M, Arthur GR, et al. Pregnancy does not alter lidocaine toxicity. Am J Obstet Gynecol 1990; 162: 1320–4PubMedGoogle Scholar
  140. 140.
    Bucklin BA, Warner DS, Choi WW, et al. Pregnancy does not alter the threshold for lidocaine-induced seizures in the rat. Anesth Analg 1992; 74: 57–61PubMedCrossRefGoogle Scholar
  141. 141.
    Bernards CM, Carpenter RL, Rupp SE, et al. Effect of mid-azolam and diazepam premedication on central nervous system and cardiovascular toxicity of bupivacaine in pigs. Anesthesiology 1989; 70: 318–23PubMedCrossRefGoogle Scholar
  142. 142.
    Torbiner ML, Yagiela JA, Mito RS. Effect of midazolam pre-treatment on the intravenous toxicity of lidocaine with and without epinephrine in rats. Anesth Analg 1989; 68: 744–9PubMedCrossRefGoogle Scholar
  143. 143.
    De Jong RH, Heavner JE. Local anesthetic seizure prevention: diazepam versus pentobarbital. Anesthesiology 1972; 36: 449–57PubMedCrossRefGoogle Scholar
  144. 144.
    Bishop D, Johnstone RE. Lidocaine toxicity treated with low-dose propofol. Anesthesiology 1993; 78: 788–9PubMedCrossRefGoogle Scholar
  145. 145.
    Peduto VA, Concas A, Santoro G, et al. Biochemical and electrophysiologic evidence that propofol enhances GABAergic transmission in the rat brain. Anesthesiology 1991; 75: 1000–9PubMedCrossRefGoogle Scholar
  146. 146.
    McFarlane C, Warner DS, Dexter F, et al. Glutamatergic antagonism: effects on lidocaine-induced seizures in the rat. Anesth Analg 1994; 79: 701–5PubMedCrossRefGoogle Scholar
  147. 147.
    Simon RP, Benowitz NL, Culala S. Motor paralysis increases brain uptake of lidocaine during status epilepticus. Neurology 1984; 34: 384–7PubMedCrossRefGoogle Scholar
  148. 148.
    Yokoyama M, Hirakawa M, Goto H. Effect of vasoconstrictive agents added to lidocaine on lidocaine-induced convulsions in rats. Anesthesiology 1995; 82: 574–80PubMedCrossRefGoogle Scholar
  149. 149.
    Dripps RD, Vandam LD. Long term follow-up of patients who received 10,098 spinal anesthetics: failure to discover major neurological sequelae. JAMA 1954; 156: 1486–91CrossRefGoogle Scholar
  150. 150.
    Phillips OC, Ebner H, Nelson AT, et al. Neurologic complications following spinal anesthesia with lidocaine: a prospective review of 10,440 cases. Anesthesiology 1969; 30: 284–9PubMedCrossRefGoogle Scholar
  151. 151.
    Kane RE. Neurologic deficit following epidural or spinal anesthesia. Anesth Analg 1981; 60: 150–61PubMedCrossRefGoogle Scholar
  152. 152.
    Ong BY, Cohen MM, Esmail A, et al. Paresthesias and motor dysfunction after labor and delivery. Anesth Analg 1987; 66: 18–22PubMedCrossRefGoogle Scholar
  153. 153.
    Dahlgren N, Tornebrandt K. Neurological complications after anaesthesia: a follow-up of 18,000 spinal and epidural anaesthetics performed over three years. Acta Anaesthesiol Scand 1995; 39: 872–80PubMedCrossRefGoogle Scholar
  154. 154.
    Dawkins CJM. An analysis of the complications of extradural and caudal block. Anaesthesia 1969; 24: 554–63PubMedCrossRefGoogle Scholar
  155. 155.
    Drasner K, Rigler ML, Sessler DI, et al. Cauda equina syndrome following intended epidural anesthesia. Anesthesiology 1992; 77: 582–5PubMedCrossRefGoogle Scholar
  156. 156.
    Rigler ML, Drasner K, Krejcie TC, et al. Cauda equina syndrome after continuous spinal anesthesia. Anesth Analg 1991; 72: 275–81PubMedCrossRefGoogle Scholar
  157. 157.
    Schell RM, Brauer FS, Cole DJ, et al. Persistent sacral nerve root deficit after continuous spinal anaesthesia. Can J Anaesth 1991; 38: 908–11PubMedCrossRefGoogle Scholar
  158. 158.
    Schneider M, Ettlin T, Kaufmann M, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg 1993; 76: 1154–7PubMedCrossRefGoogle Scholar
  159. 159.
    Cheng ACK. Intended epidural anesthesia as a possible cause of cauda equina syndrome. Anesth Anal 1994; 78: 157–9CrossRefGoogle Scholar
  160. 160.
    Hurley RJ, Lambert DH. Continuous spinal anesthesia with a microcatheter technique: preliminary experience. Anesth Analg 1990; 70: 97–102PubMedCrossRefGoogle Scholar
  161. 161.
    Drasner K, Sakura S, Chan VWS, et al. Persistent sacral sensory deficit induced by intrathecal local anesthetic infusion in the rat. Anesthesiology 1994; 80: 847–52PubMedCrossRefGoogle Scholar
  162. 162.
    FDA Safety Alert: Cauda equina syndrome associated with use of small-bore catheters in continuous spinal anaesthesia. Washington, DC: Food and Drug Administration, 1992 May 29Google Scholar
  163. 163.
    Ross BK, Coda B, Heath CM. Local anesthetic distribution in a spinal model: a possible mechanism of neurologic injury after continuous spinal anesthesia. Reg Anesth 1991; 17: 69–77Google Scholar
  164. 164.
    Beardsley D, Holman S, Gantt R, et al. Transient neurologic deficit after spinal anesthesia: local anesthetic maldistribution with pencil point needles? Anesth Analg 1995; 81: 314–20PubMedGoogle Scholar
  165. 165.
    Hampl K, Schneider M, Ummenhofer W, et al. Transient neurologic symptoms after spinal anesthesia. Anesth Analg 1995; 81: 1148–53PubMedGoogle Scholar
  166. 166.
    Sakura S, Chan VWS, Ciriales R, et al. The addition of 7.5% glucose does not alter the neurotoxicity of 5% lidocaine administered intrathecally in the rat. Anesthesiology 1995; 82: 236–40PubMedCrossRefGoogle Scholar
  167. 167.
    Ready LB, Plumer MH, Haschke RH, et al. Neurotoxicity of local anesthetics in rabbits. Anesthesiology 1985; 64: 364–70Google Scholar
  168. 168.
    Lambert LA, Lambert DH, Strichartz GR. Irreversible conduction block in isolated nerve by high concentrations of local anesthetics. Anesthesiology 1994; 80: 1082–93PubMedCrossRefGoogle Scholar
  169. 169.
    Kroin JS, Penn RD, Levy FE, et al. Effect of repetitive lidocaine infusion on peripheral nerve. Exp Neurol 1986; 94: 166–73PubMedCrossRefGoogle Scholar
  170. 170.
    Powell HC, Kalichman MW, Garrett RS, et al. Selective vulnerability of unmyelinated fiber Schwann cells in nerves exposed to local anesthetics. Lab Invest 1988; 59: 271–80PubMedGoogle Scholar
  171. 171.
    Bromage PR. ’Paraplegia following epidural analgesia’: a misnomer. Anaesthesia 1976; 31: 947–8PubMedCrossRefGoogle Scholar
  172. 172.
    Snyder R, Hui G, Flugstad P, et al. More cases of possible neurologic toxicity associated with single subarachnoid injections of 5% hyperbaric lidocaine [letter]. Anesth Analg 1994; 78: 411PubMedCrossRefGoogle Scholar
  173. 173.
    Bromage PR. Neurological complications of subarachnoid and epidural anaesthesia [editorial]. Acta Anaesthesiol Scand 1997; 41: 439–44PubMedCrossRefGoogle Scholar
  174. 174.
    de Jong RH. Last round for a ‘heavyweight’ [editorial]. Anesth Analg 1994; 78: 3–4PubMedGoogle Scholar
  175. 175.
    Carpenter RL. Hyperbaric lidocaine spinal anesthesia: Do we need an alternative? [editorial]. Anesth Analg 1995; 81: 1125–8PubMedGoogle Scholar
  176. 176.
    Scott DB, Hibbart BM. Serious non-fatal complications associated with extradural block in obstetric practice. Br J Anaesth 1990; 64: 537–41PubMedCrossRefGoogle Scholar
  177. 177.
    Crawford JS. Some maternal complications of epidural analgesia in labour. Anaesthesia 1985; 40: 1219–25PubMedCrossRefGoogle Scholar
  178. 178.
    Eng RHK, Seligman SJ. Lumber puncture induced meningitis. JAMA 1981; 245: 1456–9PubMedCrossRefGoogle Scholar
  179. 179.
    Greene NM. Neurological sequalae of spinal anesthesia. Anesthesiology 1961; 22: 682–98PubMedCrossRefGoogle Scholar
  180. 180.
    Goldmann WW, Sandford JP. An epidemic of chemical meningitis. Am J Med 1960; 29: 94–101CrossRefGoogle Scholar
  181. 181.
    Harding SA, Collis RE, Morgan BM. Meningitis after combined spinal-epidural in obstetrics. Br J Anaesth 1994; 75: 545–7CrossRefGoogle Scholar
  182. 182.
    Roberts SP, Petts HV. Meningitis after obstetric spinal anaesthesia. Anaesthesia 1990; 45: 376–7PubMedCrossRefGoogle Scholar
  183. 183.
    Sansome ATJ, Barnes GR, Barret RF. An unusual presentation of meningitis as a consequence of inadvertent dural puncture. Int J Obst Anaesth 1991; 1: 35–7CrossRefGoogle Scholar
  184. 184.
    Lee JJ, Parry H. Bacterial meningitis following spinal anaesthesia for Caesarean section. Br J Anaesth 1991; 66: 383–6PubMedCrossRefGoogle Scholar
  185. 185.
    Davis L, Hargreaves C, Robinson PN. Postpartum meningitis. Anaesthesia 1993; 48: 788–9PubMedCrossRefGoogle Scholar
  186. 186.
    Burke D, Wildsmith JAW. Meningitis after spinal anaesthesia [editorial]. Br J Anaesth 1997; 78: 635–6PubMedCrossRefGoogle Scholar
  187. 187.
    Marinac JS. Drug and chemical induced meningitis: a review of the literature. Ann Pharmacother 1992; 26: 813–21PubMedGoogle Scholar
  188. 188.
    Seigne TD. Aseptic meningitis following spinal analgesia. Anaesthesia 1970; 25: 402–7PubMedCrossRefGoogle Scholar
  189. 189.
    Blackmore TK, Morley HR, Gordon DL. Streptococcus mitis— induced bacteremia and meningitis after spinal anesthesia. Anesthesiology 1993; 78: 592–4PubMedCrossRefGoogle Scholar
  190. 190.
    Wildsmith JAW. Regional anaesthesia requires attention to detail [letter]. Br J Anaesth 1991; 67: 224–5PubMedCrossRefGoogle Scholar
  191. 191.
    Neumark J, Feichtinger W, Gassner A. Epidural block in obstetrics followed by meningoencephalitis. Anesthesiology 1980; 52: 518–9PubMedCrossRefGoogle Scholar
  192. 192.
    Berga S, Trierweiler M. Bacterial meningitis following epidural anesthesia for vaginal delivery: a case report. Am J Obstet Gynecol 1989; 74: 437–9Google Scholar
  193. 193.
    Kehlet H. Surgical stress — the role of pain and analgesia. Br J Anaesth 1989; 63: 189–95PubMedCrossRefGoogle Scholar
  194. 194.
    Kehlet H. Epidural analgesia and the endocrine-metabolic response to surgery: update and perspectives. Acta Anaesthesiol Scand 1984; 28: 125–7PubMedCrossRefGoogle Scholar
  195. 195.
    Engquist A, Brandt MR, Fernandes A, et al. The blocking effect of epidural analgesia on the adrenocortical and hyperglycaemic responses to surgery. Acta Anaesthesiol Scand 1977; 21: 330–5PubMedCrossRefGoogle Scholar
  196. 196.
    Moore CM, Cross MH, Desborough JP, et al. Hormonal effects of thoracic extradural analgesia for cardiac surgery. Br J Anaesth 1995; 75: 387–93PubMedCrossRefGoogle Scholar
  197. 197.
    Moore CM, Desborough JP, Powell H, et al. Effects of extradural anaesthesia on interleukin-6 and acute phase response to surgery. Br J Anaesth 1994; 72: 272–5PubMedCrossRefGoogle Scholar
  198. 198.
    Salo M. Effects of anaesthesia and surgery on the immune response. Acta Anaesthesiol Scand 1992; 36: 201–20PubMedCrossRefGoogle Scholar
  199. 199.
    Lee DD, Kimura S, De Quattro V. Noradrenergic activity and silent ischemia in hypertensive patients with stable angina: effect of metoprolol. Lancet 1989; I: 403–6Google Scholar
  200. 200.
    Hasselstrom LJ, Mogensen T, Kehlet H, et al. Effects of intravenous bupivacaine on cardiovascular function and plasma catecholamine levels in humans. Anesth Analg 1984; 63: 1053–8PubMedGoogle Scholar
  201. 201.
    Romano E, Gullo A. Hypoglycaemic coma following epidural analgesia. Anaesthesia 1980; 35: 1084–6PubMedCrossRefGoogle Scholar
  202. 202.
    Brennan L, Halfacre JA, Woods SD. Regional anaesthesia in porphyria. Br J Anaesth 1990; 65: 594–7PubMedCrossRefGoogle Scholar
  203. 203.
    McNeill MJ, Bennet A. Use of regional anaesthesia in a patient with acute porphyria. Br J Anaesth 1990; 64: 371–3PubMedCrossRefGoogle Scholar
  204. 204.
    Harrison GG, Meissner PN, Hift RJ. Anaesthesia for the porphyric patient. Anaesthesia 1993; 48: 417–21PubMedCrossRefGoogle Scholar
  205. 205.
    Parikh RK, Moore MR. Effect of certain anesthetic agents on the activity of rat hepatic delta-aminolevulinate synthase. Br J Anaesth 1978; 50: 1099–103PubMedCrossRefGoogle Scholar
  206. 206.
    Jensen NF, Fiddler DS, Striepe V. Anesthetic considerations in porphyrias. Anesth Analg 1995; 80: 591–9PubMedGoogle Scholar
  207. 207.
    Imrie MM, Hall GH. Body temperature and anaesthesia. Br J Anaesth 1990; 64: 346–54PubMedCrossRefGoogle Scholar
  208. 208.
    Ozaki M, Kurz A, Sessler DI, et al. Thermoregulatory thresholds during epidural and spinal anesthesia. Anesthesiology 1994; 81: 282–8PubMedCrossRefGoogle Scholar
  209. 209.
    Hynson JM, Sessler DI, Glosten B, et al. Thermal balance and tremor patterns during epidural anesthesia. Anesthesiology 1991; 74: 680–90PubMedCrossRefGoogle Scholar
  210. 210.
    Emerick TH, Ozaki M, Sessler DI, et al. Epidural anesthesia increases apparent leg temperature and decreases the shivering threshold. Anesthesiology 1994; 81: 289–98PubMedCrossRefGoogle Scholar
  211. 211.
    Joris J, Ozaki M, Sessler DI, et al. Epidural anesthesia impairs both central and peripheral thermoregulatory control during general anesthesia. Anesthesiology 1994; 80: 268–77PubMedCrossRefGoogle Scholar
  212. 212.
    Camann WR, Hortvet LA, Hughes N, et al. Maternal temperature regulation during extradural analgesia for labour. Br J Anaesth 1991; 67: 565–8PubMedCrossRefGoogle Scholar
  213. 213.
    Henkin RL. Drug-induced taste and smell disorders: incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf 1994; 11: 318–77PubMedCrossRefGoogle Scholar
  214. 214.
    Hacker JF III, Cattau Jr EL. Effects of nasopharyngeal cocaine or pharyngeal benzocaine on esophageal motility. Am J Gastroenterol 1987; 82: 127–9PubMedGoogle Scholar
  215. 215.
    Crocker JS, Vandam LD. Concerning nausea and vomiting during spinal anesthesia. Anesthesiology 1959; 20: 587–92PubMedCrossRefGoogle Scholar
  216. 216.
    Ratra CK, Badola RP, Bhargava KP. A study of factors concerned in emesis during spinal anaesthesia. Br J Anaesth 1972; 44: 1208–11PubMedCrossRefGoogle Scholar
  217. 217.
    Palazzo MGA, Strunin L. Anaesthesia and emesis: I: etiology. Can Anaesth Soc J 1984; 31: 178–87PubMedCrossRefGoogle Scholar
  218. 218.
    Dent SJ, Ramachandra V, Stephen CR. Postoperative vomiting: incidence, analysis, and therapeutic measures in 3,000 patients. Anesthesiology 1955; 16: 564–72PubMedCrossRefGoogle Scholar
  219. 219.
    Juhani TP, Hannele H. Complications during spinal anesthesia for cesarean delivery: a clinical report of one year’s experience. Reg Anesth 1993; 18: 128–31PubMedGoogle Scholar
  220. 220.
    Griffin RP, Reynolds F. Extradural anaesthesia for Caesarean section: a double-blind comparison of 0.5% ropivacaine with 0.5% bupivacaine. Br J Anaesth 1995; 74: 512–6PubMedCrossRefGoogle Scholar
  221. 221.
    Wolff AP, Hasselstrom L, Kerkkamp HE, et al. Extradural ropivacaine and bupivacaine in hip surgery. Br J Anaesthesia 1995; 74: 458–60CrossRefGoogle Scholar
  222. 222.
    Badner NH, Reid D, Sullivan P, et al. Continuous epidural infusion of ropivacaine for the prevention of postoperative pain after major orthopaedic surgery: a dose-finding study. Can J Anaesth 1996; 43: 17–22PubMedCrossRefGoogle Scholar
  223. 223.
    Hickey R, Hoffman J, Ramamurthy S. A comparison of ropivacaine 0.5% and bupivacaine 0.5% for brachial plexus block. Anesthesiology 1991; 74: 639–42PubMedCrossRefGoogle Scholar
  224. 224.
    Clark RB, Thompson DS, Thompson CH. Prevention of spinal hypotension associated with cesarean section. Anesthesiology 1976; 45: 670–4PubMedCrossRefGoogle Scholar
  225. 225.
    Lussos SA, Bader AM, Thornhill ML, et al. The antiemetic efficacy and safety of prophylactic metoclopramide for elective cesarean delivery during spinal anesthesia. Reg Anesth 1992; 17: 126–30PubMedGoogle Scholar
  226. 226.
    Freudenberger RS, Cappell MS, Hutt DA. Intestinal infarction after intravenous cocaine administration. Ann Intern Med 1990; 113: 715–6PubMedGoogle Scholar
  227. 227.
    Brandus V, Joffe S, Benoit CV, et al. Bronchial spasm during general anesthesia. Can Anaesth Soc J 1970; 17: 269–74PubMedCrossRefGoogle Scholar
  228. 228.
    Downes H, Loehning RW. Local anesthetic contracture and relaxation of airway smooth muscle. Anesthesiology 1977; 47: 430–6PubMedCrossRefGoogle Scholar
  229. 229.
    Weiss ER, Anderson WH, O’Brien KP. The effect of a local anesthetic, lidocaine, on guinea pig trachealis muscle in vitro. Am Rev Respir Dis 1975; 112: 393–400PubMedGoogle Scholar
  230. 230.
    Mallampati SR. Bronchospasm during spinal anesthesia. Anesth Analg 1981; 60: 839–40PubMedCrossRefGoogle Scholar
  231. 231.
    Thiagarajah S, Lear E, Azar I, et al. Bronchospasm following interscalene brachial plexus block. Anesthesiology 1984; 61: 759–61PubMedCrossRefGoogle Scholar
  232. 232.
    Dahlstrom A, Fuxe K, Hokfelt T, et al. Adrenergic innervation of the bronchial muscle of the cat. Acta Physiol Scand 1966; 66: 507–8PubMedCrossRefGoogle Scholar
  233. 233.
    Lumb AB, Carli F. Respiratory arrest after a caudal injection of bupivacaine. Anaesthesia 1989; 44: 324–5PubMedCrossRefGoogle Scholar
  234. 234.
    Cory PC, Mulroy MF. Postoperative respiratory failure following intercostal block. Anesthesiology 1981; 54: 418–9PubMedCrossRefGoogle Scholar
  235. 235.
    Rodman DJ, Notaro S, Peer GL. Respiratory depression following retrobulbar bupivacaine: three case reports and literature review. Ophthalmic Surg 1987; 18: 768–71PubMedGoogle Scholar
  236. 236.
    Holmboe J, Kongsrud F. Delayed respiratory arrest after bupivacaine. Anaesthesia 1982; 37: 60–2PubMedCrossRefGoogle Scholar
  237. 237.
    Parnass SM, Schmidt KJ. Adverse effects of spinal and epidural anaesthesia. Drug Saf 1990; 5: 179–94PubMedCrossRefGoogle Scholar
  238. 238.
    Howard JJ, Mohsenifar Z, Simons SM. Adult respiratory distress syndrome following administration of lidocaine. Chest 1982; 81: 644–5PubMedCrossRefGoogle Scholar
  239. 239.
    McBurney A, Jones DA, Stanley PJ, et al. Absorption of lignocaine and bupivacaine from the respiratory tract during fibreoptic bronchoscopy. Br J Clin Pharmacol 1984; 17: 61–6PubMedCrossRefGoogle Scholar
  240. 240.
    Uehira A, Tanaka A, Oda M, et al. Obstruction of an endotracheal tube by lidocaine jelly. Anesthesiology 1981; 55: 598–9PubMedCrossRefGoogle Scholar
  241. 241.
    Levin ML, O’Connor PS. Visual acuity after retrobulbar anesthesia. Ann Ophthalmol 1989; 11: 337–9Google Scholar
  242. 242.
    Brent BD, Singh H. The effect of retrobulbar anesthesia on visual acuity in planned extracapsular cataract extraction. Ophthalmic Surg 1991; 22: 392–5PubMedGoogle Scholar
  243. 243.
    Cowley M, Campochiaro PA, Newman SA, et al. Retinal vascular occlusion without retrobulbar or optic nerve sheath hemorrhage after retrobulbar injection of lidocaine. Ophthalmic Surg 1988; 19: 859–61PubMedGoogle Scholar
  244. 244.
    Vester-Andersen T, Christiansen C, Hansen A, et al. Interscalene brachial plexus block: area of analgesia, complications and blood concentrations of local anesthetics. Acta Anaesthesiol Scand 1981; 25: 81–4PubMedCrossRefGoogle Scholar
  245. 245.
    Hickey R, Garland TA, Ramaurthy S. Subclavian perivascular block: influence of location of paresthesia. Anesth Analg 1989; 68: 767–71PubMedCrossRefGoogle Scholar
  246. 246.
    Mohan J, Potter JM. Pupillary constriction and ptosis following caudal epidural analgesia. Anaesthesia 1975; 30: 769–73PubMedCrossRefGoogle Scholar
  247. 247.
    Clayton KC. The incidence of Horner’s syndrome during lumbar extradural for elective caesarean section and provision of analgesia during labour. Anaesthesia 1983; 8: 583–5Google Scholar
  248. 248.
    Mohan J, Lloyd JW, Potter JM. Pupillary constriction following extradural analgesia. Injury 1973; 5: 151–2PubMedCrossRefGoogle Scholar
  249. 249.
    Winnie AP, Ramamurthy S, Durrani Z, et al. Pharmacological reversal of Horner’s syndrome following stellate ganglion block. Anesthesiology 1974; 41: 615–7PubMedCrossRefGoogle Scholar
  250. 250.
    Hamilton RC, Gimbel HV, Strunin L. Regional anaesthesia for 12000 cataract extraction and intraocular lens implantation procedures. Can J Anaesth 1988; 35: 615–23PubMedCrossRefGoogle Scholar
  251. 251.
    Rao VA, Kawatra VK. Ocular myotoxic effects of local anaesthetics. Can J Ophthalmol 1988; 23: 171–3PubMedGoogle Scholar
  252. 252.
    De Faber JT, Von Noorden GK. Inferior rectus muscle palsy after retrobulbar anesthesia for cataract surgery. Am J Ophthalmol 1991; 112: 209–11PubMedGoogle Scholar
  253. 253.
    Hamed LM, Mancuso A. Inferior rectus muscle contracture syndrome after retrobulbar anesthesia. Ophthalmology 1991; 98: 1506–12PubMedGoogle Scholar
  254. 254.
    Ong-Tone L, Pearce WG. Inferior rectus muscle restriction after retrobulbar anaesthesia for cataract extraction. Can J Ophthalmol 1989; 24: 162–5PubMedGoogle Scholar
  255. 255.
    Carlson BM, Rainin EA. Rat extraocular muscle regeneration: repair of local anesthetic-induced damage. Arch Ophthalmol 1985; 103: 1373–7PubMedCrossRefGoogle Scholar
  256. 256.
    Rainin EA, Carlson BM. Postoperative diplopia and ptosis: a clinical hypothesis based on the myotoxicity of local anesthetics. Arch Ophthalmol 1985; 103: 1337–9PubMedCrossRefGoogle Scholar
  257. 257.
    Yagiela JA, Benoit PW, Buoncristiani RD, et al. Comparison of myotoxic effects of lidocaine with epinephrine in rats and humans. Anesth Analg 1981; 60: 471–80PubMedCrossRefGoogle Scholar
  258. 258.
    Foster AH, Carlson BM. Myotoxicity of local anesthetics and regeneration of the damaged muscle fibers. Anesth Analg 1980; 59: 727–36PubMedCrossRefGoogle Scholar
  259. 259.
    Brun A. Effect of procaine, Carbocaine and xylocaine on cutaneous muscle in rabbits and mice. Acta Anaesthesiol Scand 1959; 3: 59–73PubMedCrossRefGoogle Scholar
  260. 260.
    Benoit PW, Belt D. Destruction and regeneration of skeletal muscle after treatment with a local anesthetic, bupivacaine (Marcaine). J Anat 1970; 107: 547–56PubMedGoogle Scholar
  261. 261.
    Benoit PW, Belt WD. Some effects of local anesthetic agents on skeletal muscle. Exp Neurol 1972; 34: 264–78PubMedCrossRefGoogle Scholar
  262. 262.
    Guttu RL, Page DG, Laskin DM. Delayed healing of muscle after injection of bupivacaine and steroid. Ann Dent 1990; 49: 5–8PubMedGoogle Scholar
  263. 263.
    Benoit PW. Reversible skeletal muscle damage after administration of local anesthetics with and without epinephrine. J Oral Surg 1978; 36: 198–201PubMedGoogle Scholar
  264. 264.
    Komorowski TE, Shepard B, Okland S, et al. An electron microscopic study of local anesthetic-induced skeletal muscle fiber degeneration and regeneration in the monkey. J Orthop Res 1990; 8: 495–503PubMedCrossRefGoogle Scholar
  265. 265.
    Schultz E, Lipton BH. The effect of Marcaine on muscle and non-muscle cells in vitro. Anat Res 1978; 191: 351–69CrossRefGoogle Scholar
  266. 266.
    Benoit PW, Yagiela JA, Fort NF. Pharmacological correlation between local anesthetic-induced myotoxicity and disturbances of intracellular calcium distribution. Toxicol Appl Pharmacol 1980; 52: 187–98PubMedCrossRefGoogle Scholar
  267. 267.
    Brownell AKW, Paasuke RT. Use of local anesthetics in malignant hyperthermia. Can Med Assoc J 1986; 134: 993–4Google Scholar
  268. 268.
    Adragna MG. Medical protocol by habit — the avoidance of amide local anesthetics in malignant hyperthermia susceptible patients. Anesthesiology 1985; 62: 99–100PubMedCrossRefGoogle Scholar
  269. 269.
    MacArthur C, Lewis M, Knox EG, et al. Epidural anaesthesia and long term backache after childbirth. BMJ 1990; 301: 9–12PubMedCrossRefGoogle Scholar
  270. 270.
    Grove LH. Backache, headache and bladder dysfunction after delivery. Br J Anaesth 1973; 45: 1147–9PubMedCrossRefGoogle Scholar
  271. 271.
    Stevens RA, Chester WL, Artuso JD, et al. Back pain after epidural anesthesia in volunteers: a preliminary report. Reg Anesth 1991; 16: 199–203PubMedGoogle Scholar
  272. 272.
    Hynson JM, Sessler DI, Glosten B. Back pain in volunteers after epidural anesthesia with chloroprocaine. Anesth Analg 1991; 72: 253–6PubMedCrossRefGoogle Scholar
  273. 273.
    Levy L, Randel GI, Pandit SK. Does chloroprocaine (Nesacaine MPF) for epidural anesthesia increase the incidence of backache? [letter] Anesthesiology 1989; 71: 476PubMedCrossRefGoogle Scholar
  274. 274.
    Stevens RA, Urmey WE, Urquhart BL, et al. Back pain after epidural anesthesia with chloroprocaine. Anesthesiology 1993; 78: 492–7PubMedCrossRefGoogle Scholar
  275. 275.
    Bircher AJ, Messmer SL, Surber C, et al. Delayed-type hyper-sensitivity to subcutaneous lidocaine with tolerance to articaine: confirmation by in vivo and in vitro tests. Contact Dermatitis 1996; 34: 387–9PubMedCrossRefGoogle Scholar
  276. 276.
    Rood JP. A case of lignocaine hypersensitivity. Br Dent J 1973; 135: 411–2PubMedCrossRefGoogle Scholar
  277. 277.
    Yeoman CM. Hypersensitivity to prilocaine. Br Dent J 1982; 153: 69–70PubMedCrossRefGoogle Scholar
  278. 278.
    Moriwaki K, Higaki A, Sasaki H, et al. A case report of anaphylactic shock induced by tetracaine used for spinal anesthesia. Masui 1986; 35: 1279–84PubMedGoogle Scholar
  279. 279.
    Promisloff RA, DuPont DC. Death from ARDS and cardiovascular collapse following lidocaine administration [letter]. Chest 1983; 83: 585PubMedCrossRefGoogle Scholar
  280. 280.
    Brown DT, Beamish D, Wildsmith JA. Allergic reaction to an amide local anesthetic. Br J Anaesth 1981; 53: 435–7PubMedCrossRefGoogle Scholar
  281. 281.
    Ruzicka T, Gerstmeir M, Przybilla B, et al. Allergy to local anesthetics: comparison of patch test with prick and intradermal test results. J Am Acad Dermatol 1987; 16: 1202–8PubMedCrossRefGoogle Scholar
  282. 282.
    Fisher MM, Pennington JC. Allergy to local anesthesia. Br J Anaesth 1982; 54: 893–94PubMedCrossRefGoogle Scholar
  283. 283.
    Fisher MM, Graham R. Adverse responses to local anesthetics. Anaesth Intens Care 1984; 12: 325–7Google Scholar
  284. 284.
    Chandler MJ, Grammer LC, Patterson R. Provocative challenge with local anesthetics in patients with a prior history of reactions. J Allergy Clin Immunol 1987; 79: 883–6PubMedCrossRefGoogle Scholar
  285. 285.
    Watkins J. Second report from an anaesthetic reactions advisory service. Anaesthesia 1989; 44: 157–9PubMedCrossRefGoogle Scholar
  286. 286.
    Fung DL, Schatz H. Surgery in allergic patients. In: Bierman CW, Pearlman DS, editors. Allergic diseases from infancy to adulthood. Philadelphia: WB Saunders, 1988: 748–59Google Scholar
  287. 287.
    Weiss ME. Drug allergy. Med Clin North Am 1992; 76: 857–82PubMedGoogle Scholar
  288. 288.
    Stoelting RK. Allergic reactions during anesthesia. Anesth Analg 1983; 62: 341–56PubMedCrossRefGoogle Scholar
  289. 289.
    McKinnon RP, Wildsmith JAW. Histaminoid reactions in anaesthesia. Br J Anaesth 1995; 74: 217–28PubMedCrossRefGoogle Scholar
  290. 290.
    Ralston DH, Shnider SM. The fetal and neonatal effects of regional anesthesia in obstetrics. Anesthesiology 1978; 48: 34–64PubMedCrossRefGoogle Scholar
  291. 291.
    Brizgys RV, Dailey PA, Shnider SM, et al. The incidence and neonatal effects of maternal hypotension during epidural anesthesia for cesarean section. Anesthesiology 1987; 67: 782–6PubMedCrossRefGoogle Scholar
  292. 292.
    Jouppila R, Jouppila P, Kuikka J, et al. Placental blood flow during caesarean section under lumbar extradural analgesia. Br J Anaesth 1978; 50: 275–9PubMedCrossRefGoogle Scholar
  293. 293.
    Scanlon JW, Brown WU, Weiss JB, et al. Neurobehavioral responses of newborn infants after maternal epidural anesthesia. Anesthesiology 1974; 40: 121–8PubMedCrossRefGoogle Scholar
  294. 294.
    Abouleish E. Foetal bradycardia during caudal analgesia: a discussion of possible causative factors. Br J Anaesth 1976; 48: 481–4PubMedCrossRefGoogle Scholar
  295. 295.
    Abboud TK, Kim KC, Noueihed R, et al. Epidural bupivacaine, chloroprocaine, or lidocaine for cesarean section — maternal and neonatal effects. Anesth Analg 1983; 62: 914–9PubMedGoogle Scholar
  296. 296.
    Loftus JR, Holbrook RH, Cohen SE. Fetal heart rate after epidural lidocaine and bupivacaine for elective cesarean section. Anesthesiology 1991; 75: 406–12PubMedCrossRefGoogle Scholar
  297. 297.
    Kileff ME, James FM III, Dewan DM, et al. Neonatal neurobehavioral responses after epidural anesthesia for cesarean section using lidocaine and bupivacaine. Anesth Analg 1984; 63: 413–7PubMedCrossRefGoogle Scholar
  298. 298.
    Abboud TK, Afrasiabi A, Sarkis F, et al. Continuous infusion epidural analgesia in parturients receiving bupivacaine, chloroprocaine, or lidocaine — maternal, fetal, and neonatal effects. Anesth Analg 1984; 63: 421–8PubMedGoogle Scholar
  299. 299.
    Stienstra R, Jonker TA, Bourdrez P, et al. Ropivacaine 0.25% versus bupivacaine 0.25% for continuous epidural analgesia in labor: a double-blind comparison. Anesth Analg 1995; 80: 285–9PubMedGoogle Scholar
  300. 300.
    Brown WR, Bell GC, Alper MH. Acidosis, local anesthesia and the newborn. Obstet Gynecol 1976; 48: 27–30PubMedGoogle Scholar
  301. 301.
    Van Dorsten JP, Miller FC. Fetal heart rate changes after accidental intrauterine lidocaine. Obstet Gynecol 1981; 57: 257–9PubMedGoogle Scholar
  302. 302.
    Abouleish EI. Epinephrine improves the quality of spinal hyperbaric bupivacaine for cesarean section. Anesth Analg 1987; 66: 395–400PubMedGoogle Scholar
  303. 303.
    Eisenach JC, Grice SC, Dewan DM. Epinephrine enhances analgesia produced by epidural bupivacaine during labor. Anesth Analg 1987; 66: 447–51PubMedCrossRefGoogle Scholar
  304. 304.
    Chin GN, Almquist HT. Bupivacaine and lidocaine retrobulbar anaesthesia: a double-blind clinical study. Ophthalmology 1983; 90: 369–72PubMedGoogle Scholar
  305. 305.
    Sinclair CJ, Scott DB. Comparison of bupivacaine and etidocaine in extradural blockade. Br J Anaesth 1984; 56: 147–53PubMedCrossRefGoogle Scholar
  306. 306.
    Buckley FP, Littlewood DG, Covino BG, et al. Effects of adrenaline and the concentration of solution on extradural block with etidocaine. Br J Anaesth 1978; 50: 171–5PubMedCrossRefGoogle Scholar
  307. 307.
    Racle JP, Benkhadra A, Poy JY, et al. Prolongation of isobaric bupivacaine spinal anesthesia with epinephrine and clonidine for hip surgery in the elderly. Anesth Analg 1987; 66: 442–6PubMedGoogle Scholar
  308. 308.
    Eledjam JJ, Deschodt J, Viel EJ, et al. Brachial plexus block with bupivacaine: effects of added alpha-adrenergic agonists: comparison between clonidine and epinephrine. Can J Anaesth 1991; 38: 870–5PubMedCrossRefGoogle Scholar
  309. 309.
    Nishikawa T, Dohi S. Clinical evaluation of clonidine added to lidocaine solution for epidural anesthesia. Anesthesiology 1990; 73: 853–9PubMedCrossRefGoogle Scholar
  310. 310.
    Garty M, Ben-Zvi Z, Hurwitz A. Interaction of clonidine and morphine with lidocaine in mice and rats. Toxicol Appl Pharmacol 1989; 101: 255–60PubMedCrossRefGoogle Scholar
  311. 311.
    Bruguerolle B, Attolini L, Lorec AM, et al. Kinetics of bupivacaine after clonidine pretreatment in mice. Can J Anaesth 1995; 42: 434–7PubMedCrossRefGoogle Scholar
  312. 312.
    Mazoit JX, Benhamou D, Veillette Y, et al. Clonidine and or adrenaline decrease lignocaine plasma peak concentration after epidural injection. Br J Clin Pharmacol 1996; 42: 242–5PubMedCrossRefGoogle Scholar
  313. 313.
    De Kock M, Le Polain B, Henin D, et al. Clonidine pretreatment reduces the systemic toxicity of intravenous bupivacaine in rats. Anesthesiology 1993; 79: 282–9PubMedCrossRefGoogle Scholar
  314. 314.
    Yokoyama M, Hirakawa M, Goto H. Clonidine does not affect lidocaine seizure threshold in rats. Can J Anaesth 1993; 40: 1205–9PubMedCrossRefGoogle Scholar
  315. 315.
    Nicoll JMV, Treuren B, Acharya A, et al. Retrobulbar anesthesia: the role of hyaluronidase. Anesth Analg 1986; 65: 1324–8PubMedCrossRefGoogle Scholar
  316. 316.
    Sarvela J, Nikki P. Hyaluronidase improves regional ophthalmic anaesthesia with etidocaine. Can J Anaesth 1992; 39: 920–4PubMedCrossRefGoogle Scholar
  317. 317.
    Mindel JS. Value of hyaluronidase in ocular surgical akinesia. Am J Ophthalmol 1978; 85: 643–6PubMedGoogle Scholar
  318. 318.
    Morsman CD, Holden R. The effects of adrenaline, hyaluronidase and age on peribulbar anaesthesia. Eye 1992; 6: 290–2PubMedCrossRefGoogle Scholar
  319. 319.
    Barr J, Kirkpatrick N, Dick A, et al. Effects of adrenaline and hyaluronidase on plasma concentrations of lignocaine and bupivacaine after peribulbar anaesthesia. Br J Anaesth 1995; 75: 692–7PubMedCrossRefGoogle Scholar
  320. 320.
    Kaplan JA, Miller Jr ED, Gallagher EG. Postoperative analgesia for thoracotomy patients. Anesth Analg 1975; 54: 773–7PubMedGoogle Scholar
  321. 321.
    Scurlock JE, Curtis BM. Dextran-local anesthetic interactions. Anesth Analg 1980; 59: 335–40PubMedCrossRefGoogle Scholar
  322. 322.
    Mather LE, Tucker GT, Murphy TM, et al. Hemodynamic drug interaction: peridural lidocaine and intravenous ephedrine. Acta Anaesthesiol Scand 1976; 20: 207–10PubMedCrossRefGoogle Scholar
  323. 323.
    Herzig S, Ruhnke L, Wulf H. Functional interaction between local anaesthetics and calcium antagonists in guineapig myocardium: 1. Cardiodepressant effects in isolated organs. Br J Anaesth 1994; 73: 357–63PubMedCrossRefGoogle Scholar
  324. 324.
    Geraets DR, Scott SD, Ballew KA. Toxicity potential of oral lidocaine in a patient receiving mexiletine. Ann Pharmacother 1992; 26: 1380–1PubMedGoogle Scholar
  325. 325.
    Christie JM, Valdes C, Markowsky SJ. Neurotoxicity of lidocaine combined with mexiletine. Anesth Analg 1993; 77: 1291–4PubMedGoogle Scholar
  326. 326.
    Ellrodt G, Singh BN. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents. Heart Lung 1980; 9: 469–74PubMedGoogle Scholar
  327. 327.
    Ilyas M, Owens D, Kvasnicka G. Delirium induced by a combination of anti-arrhythmic drugs. Lancet 1969; II: 1368–9CrossRefGoogle Scholar
  328. 328.
    Keidar S, Grenadier E, Palant A. Sinoatrial arrest due to lidocaine injection in sick sinus syndrome during amiodarone administration. Am Heart J 1982; 104: 1384–5PubMedCrossRefGoogle Scholar
  329. 329.
    Nattel S, Talajic M, Beaudoin D, et al. Absence of pharmacokinetic interaction between amiodarone and lidocaine. Am J Cardiol 1994; 73: 92–4PubMedCrossRefGoogle Scholar
  330. 330.
    Heinonen J, Takkis S, Jarho L. Plasma lidocaine levels in patients treated with potential inducers of microsomal enzymes. Acta Anaesthesiol Scand 1970; 14: 89–95PubMedCrossRefGoogle Scholar
  331. 331.
    Perucca E, Hedges A, Makki KA, et al. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme inducing drugs. Br J Clin Pharmacol 1980; 10: 491–7PubMedCrossRefGoogle Scholar
  332. 332.
    Bruguerolle B. Effects of calcium channel blockers on bupivacaine-induced toxicity. Life Sci 1993; 53: 349–53CrossRefGoogle Scholar
  333. 333.
    Bruguerolle B, Lorec AM. Bupivacaine kinetic changes induced by diltiazem in mice. Life Sci 1994; 54: 315–9CrossRefGoogle Scholar
  334. 334.
    Hyman SA, Kinney WW, Horn J-L, et al. Nimodipine reduces the toxicity of intravenous bupivacaine in rats. Anesth Analg 1992; 74: 851–5PubMedCrossRefGoogle Scholar
  335. 335.
    Conrad KA, Byers MJ III, Finley PR, et al. Lidocaine elimination: effects of metoprolol and of propranolol. Clin Pharmacol Ther 1983; 33: 133–8PubMedCrossRefGoogle Scholar
  336. 336.
    Ochs HR, Carstens G, Greenblatt DJ. Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol. N Engl J Med 1980; 303: 373–8PubMedCrossRefGoogle Scholar
  337. 337.
    Schneck DW, Luderer JR, Davis D, et al. Effects of nadolol and propranolol on plasma lidocaine clearance. Clin Pharmacol Ther 1984; 36: 584–7PubMedCrossRefGoogle Scholar
  338. 338.
    Ponten J, Biber B, Bruro T, et al. Beta-receptor blockade and spinal anaesthesia: withdrawal versus continuation of long-term therapy. Acta Anaesthesiol Scand 1982; 76 Suppl.: 62–9CrossRefGoogle Scholar
  339. 339.
    Ponten J, Biber B, Henriksson BA, et al. Bupivacaine for intercostal nerve blockade in patients on long-term beta-receptor blocking therapy. Acta Anaesthesiol Scand 1982; 76 Suppl.: 70–77CrossRefGoogle Scholar
  340. 340.
    Hartrick CT, Dirkes WE, Raj PP. Influence of bupivacaine on mepivacaine protein binding. Clin Pharmacol Ther 1984; 36: 546–50PubMedCrossRefGoogle Scholar
  341. 341.
    Ghoneim MM, Pandya H. Plasma protein binding of bupivacaine and its interaction with other drugs in man. Br J Anaesth 1974; 46: 435–8PubMedCrossRefGoogle Scholar
  342. 342.
    Feely J, Guy E. Lack of effect of ranitidine on the disposition of lignocaine. Br J Clin Pharmacol 1983; 15: 378–9PubMedCrossRefGoogle Scholar
  343. 343.
    Jackson JE, Bentley JB, Glass S, et al. Effects of histamine-2 receptor blockade on lidocaine kinetics. Clin Pharmacol Ther 1985; 37: 544–8PubMedCrossRefGoogle Scholar
  344. 344.
    Klotz U. Lack of effect of nizatidine on drug metabolism. Scand J Gastroenterol 1987; 22 Suppl. 136: 18–23CrossRefGoogle Scholar
  345. 345.
    Feely, Wilkinson GR, McAllister CB, et al. Increased toxicity and reduced clearance of lidocaine by cimetidine. Ann Intern Med 1982; 96: 592–4PubMedGoogle Scholar
  346. 346.
    Kuhnert BR, Zuspan KJ, Kuhnert PM, et al. Lack of influence of cimetidine on bupivacaine levels during parturition. Anesth Analg 1987; 66: 986–90PubMedGoogle Scholar
  347. 347.
    Flynn RJ, Moore J, Collier PS, et al. Does pretreatment with cimetidine and ranitidine affect the disposition of bupivacaine? Br J Anaesth 1989; 62: 87–91PubMedCrossRefGoogle Scholar
  348. 348.
    Calvo R, Carlos R, Erill S. Effects of disease and acetazolamide on procaine hydrolysis by red blood cell enzymes. Clin Pharmacol Ther 1980; 27: 179–83PubMedCrossRefGoogle Scholar
  349. 349.
    Brodsky JB, Campos FA. Chloroprocaine analgesia in a patient receiving echothiophate iodide eye drops. Anesthesiology 1978; 48: 288–9PubMedCrossRefGoogle Scholar
  350. 350.
    Carabine UA, Wright PMC, Moore J. Extradural clonidine and bupivacaine for postoperative analgesia. Br J Anaesth 1992; 68: 132–5PubMedCrossRefGoogle Scholar
  351. 351.
    Bonnet F, Brun-Buisson V, Saada M, et al. Dose-related prolongation of hyperbaric tetracaine spinal anesthesia by clonidine in humans. Anesth Analg 1989; 68: 619–22PubMedCrossRefGoogle Scholar
  352. 352.
    Carp H, Jayaram A, Morrow D. Intrathecal cholinergic agonists lessen bupivacaine spinal-block-induced hypotension in rats. Anesth Analg 1994; 79: 112–6PubMedGoogle Scholar
  353. 353.
    Foster CA, Aston SJ. Propranolol-epinephrine interaction: a potential disaster. Plast Reconstr Surg 1983; 72: 74–8PubMedCrossRefGoogle Scholar
  354. 354.
    Dzubow LM. The interaction between propranolol and epinephrine as observed in patients undergoing Mohs’ surgery. J Am Acad Dermatol 1986; 15: 71–5PubMedCrossRefGoogle Scholar
  355. 355.
    Wood RA. Sinoatrial arrest: an interaction between phenytoin and lignocaine. BMJ 1971; 1: 645PubMedCrossRefGoogle Scholar
  356. 356.
    Matsuo S, Rao DB, Chaudry I, et al. Interaction of muscle relaxants and local anesthetics at the neuromuscular junction. Anesth Analg 1978; 57: 580–7PubMedGoogle Scholar
  357. 357.
    Harrah MD, Way WL, Katzung BG. The interaction of d-tubocurarine with antiarrhythmic drugs. Anesthesiology 1970; 33: 406–10PubMedCrossRefGoogle Scholar
  358. 358.
    Bruckner J, Thomas Jr KC, Bikhazi GB, et al. Neuromuscular drug interactions of clinical importance. Anesth Analg 1980; 59: 678–82PubMedGoogle Scholar
  359. 359.
    Himes Jr RS, DiFazio CA, Burney RG. Effects of lidocaine on the anesthetic requirements for nitrous oxide and halothane. Anesthesiology 1977; 47: 437–40PubMedCrossRefGoogle Scholar
  360. 360.
    Bruguerolle B, Emperaire N. Flumazenil and bupivacaine-induced toxicity: inverse agonist type activity. Life Sci 1991; 49: 185–8CrossRefGoogle Scholar
  361. 361.
    Bruguerolle B, Lorec AM. Lack of bupivacaine kinetic changes induced by flumazenil in mice. Life Sci 1993; 52: 165–7Google Scholar
  362. 362.
    Åkerman B, Arweström E, Post C. Local anesthetics potentiate spinal morphine antinociception. Anesth Analg 1988; 67: 943–8PubMedGoogle Scholar
  363. 363.
    Maves TJ, Gebhart GF. Antinociceptive synergy between intrathecal morphine and lidocaine during visceral and somatic nociception in the rat. Anesthesiology 1992; 76: 91–9PubMedCrossRefGoogle Scholar
  364. 364.
    Abouleish E, Rawal N, Shaw J, et al. Intrathecal morphine 0.2 mg versus epidural bupivacaine 0.125% or their combination: effects on parturients. Anesthesiology 1991; 74: 711–6PubMedCrossRefGoogle Scholar
  365. 365.
    Hunt CO, Naulty JS, Bader AM, et al. Perioperative analgesia with subarachnoid fentanyl-bupivacaine for cesarean delivery. Anesthesiology 1989; 71: 535–40PubMedCrossRefGoogle Scholar
  366. 366.
    Omoigui S. The anesthesia drugs handbook. 2nd ed. St Louis, MO: Mosby-Year Book Inc., 1995: 48–341Google Scholar
  367. 367.
    Brown DL, Ransom DM, Hall JA, et al. Regional anesthesia and local anesthetic-induced systemic toxicity: seizure frequency and accompanying cardiovascular changes. Anesth Analg 1995; 81: 321–8PubMedGoogle Scholar
  368. 368.
    Tanaka K, Watanabe R, Harada T, et al. Extensive application of epidural anesthesia and analgesia in a university hospital: incidence of complications related to technique. Reg Anesth 1993; 18: 34–8PubMedGoogle Scholar

Copyright information

© Adis International Limited 1998

Authors and Affiliations

  • Mohamed Naguib
    • 1
  • Magboul M. A. Magboul
    • 1
  • Abdulhamid H. Samarkandi
    • 1
  • Mounir Attia
    • 1
  1. 1.Department of Anaesthesiology, College of MedicineKing Khalid University HospitalRiyadhSaudi Arabia

Personalised recommendations